Dr. François Robert, molecular biology researcher at the Institut de recherches cliniques de Montréal (IRCM), and his team confirmed that the phosphorylation of RNA polymerase II, a key enzyme in the process of gene expression, is uniform across all genes. This discovery, which contributes to numerous debates on the topic within the scientific community, will be published tomorrow in the scientific journal Molecular Cell.
Phosphorylation, or the addition of phosphate to a molecule, is one of the most important regulation mechanisms for cells. It allows, among other things, to control interactions between proteins.
"During transcription, the first step in gene expression, RNA polymerase II is abundantly phosphorylated," explains Dr. Robert, Director of the Chromatin and Genomic Expression research unit at the IRCM. "This allows for the coordination between transcription and the other steps in the process of gene expression."
By examining a small number of genes, certain pioneering studies that have been long-accepted in the field had shown that phosphorylation of RNA polymerase II always occurred in the same prescribed pattern during transcription. However, recent genome-wide analyses challenged this idea by suggesting that this process was not uniform across different genes. "The latter model is very controversial, because it is unclear how, or why, transcription could work in such radically different ways from one gene to the next," says Alain Bataille, doctoral student and first co-author of the study.
By using modern functional genomic tools, the team of researchers confirmed the former hypothesis that transcription operates in a uniform way across virtually all genes.
"The identity of enzymes responsible for adding and removing phosphate groups to RNA polymerase II is another controversial topic among scientists," adds Dr. Célia Jeronimo, postdoctoral fellow in Dr. Robert's laboratory and first co-author of the article. "Our research also allowed us to better understand the respective role of these essential enzymes."
About Dr. François Robert
François Robert obtained his PhD in molecular biology from the Université de Sherbrooke. He is Associate IRCM Research Professor, Director of the Systems Biology and Medicinal Chemistry research program, and Director of the Chromatin and Genomic Expression research unit. Dr. Robert is an associate researcher-professor in the Department of Medicine (accreditation in molecular biology) at the Université de Montréal. He is also adjunct professor in the Department of Biology at the Université de Sherbrooke.
About the Institut de recherches cliniques de Montréal (IRCM)
Founded in 1967, the IRCM (http://www.ircm.qc.ca) is currently comprised of 36 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses three specialized research clinics, seven core facilities and three research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University.
Julie Langelier | EurekAlert!
Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex
New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center
In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.
Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
22.06.2018 | Materials Sciences
22.06.2018 | Earth Sciences
22.06.2018 | Life Sciences